CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Cash flows from operating activities:      
Net loss   $ (36,836) $ (24,178)
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation expense $ 2,344 5,935 1,823
Depreciation and amortization 107 191 106
Change in fair value of warrant liability     5,452
Net amortization of premiums and discounts on short-term investments   (899) (1,171)
Noncash interest expense   94 40
Changes in operating assets and liabilities:      
Research and development incentives receivable   (2,184) 340
Prepaid expenses and other current assets   (1,520) (589)
Operating lease, right-of-use-asset   421  
Finance lease, right-of-use-asset   666  
Long term prepaid rent   (14,051)  
Accounts payable   (2,585) (521)
Accrued expenses and other current liabilities   1,781 (767)
Operating lease liabilities   (303)  
Deferred rent     120
Net cash used in operating activities   (49,290) (19,345)
Cash flows from investing activities:      
Purchases of property, plant and equipment   (5,202) (752)
Purchase of short-term investments   (119,611) (134,624)
Proceed from sales and maturities of short-term investments   111,739 58,958
Net cash provided by (used in) investing activities   (13,074) (76,418)
Cash flows from financing activities:      
Proceeds from issuance of common stock in follow-on public offering, net of underwriting fees and discounts   57,453  
Proceeds from issuance of prefunded warrants to purchase common stock, net of underwriting fees and discounts   28,145  
Proceeds from issuance of common stock through ATM sales   4,431  
Proceeds from long-term debt   10,000  
Payment of issuance costs   (355) (2,157)
Exercise of stock options   480 165
Proceeds from issuance of common stock in initial public offering, net of underwriting fees and discounts     103,341
Principal payment of finance lease obligation (22) (22)  
Net cash provided by financing activities   100,132 101,349
Effect of exchange rate changes on cash, cash equivalents and restricted cash   (20) (1,009)
Net increase in cash, cash equivalents and restricted cash   37,748 4,577
Cash, cash equivalents and restricted cash at beginning of period   26,890 17,661
Cash, cash equivalents and restricted cash at end of period 64,638 64,638 22,238
Supplemental Cash Flow Information [Abstract]      
Interest Paid, Excluding Capitalized Interest, Operating Activities   282  
Supplemental disclosure of non-cash investing and financing activities:      
Conversion of convertible preferred stock warrants into common stock warrants     7,094
Conversion of convertible preferred stock into common stock 28,145   86,361
Purchases of property and equipment included in accounts payable     108
Lease assets obtained in exchange for new financing lease liabilities 48,224 48,224  
Lease assets obtained in exchange for new operating lease liabilities $ 5,152 $ 5,152  
Amounts capitalized under build-to-suit lease transaction     $ 4,932